Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Radiotherapy Devices Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The radiotherapy devices market has experienced robust growth in recent years. It is projected to expand from $6.64 billion in 2025 to $7.21 billion in 2026, indicating a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be linked to factors such as the rising global incidence rates of cancer, the broadening of oncology treatment infrastructure, the increasing uptake of external beam radiation therapies, advancements in linear accelerator performance, and the greater availability of sophisticated radiotherapy techniques.
The radiotherapy devices market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $10.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This forecasted growth can be attributed to the increasing demand for personalized cancer treatment, rising investments in proton therapy centers, the expansion of AI-assisted oncology workflows, a greater emphasis on reducing radiation side effects, and ongoing technological innovation in radiation delivery systems. Significant trends during this period are expected to include the increasing adoption of image-guided radiation therapy systems, the rising deployment of proton therapy technologies, the growing integration of AI-based treatment planning, the expansion of stereotactic radiation techniques, and an enhanced focus on precision dose delivery.
Get A Free Sample Report With In-Depth Market Insights:
Radiotherapy Devices Market Industry Drivers: What’s Behind The Revenue Growth?
A rise in cancer prevalence is anticipated to drive expansion in the radiotherapy devices market. This refers to the overall count or percentage of individuals within a population identified with cancer at a specific moment or throughout a defined timeframe. Radiotherapy serves as a frequent primary or supplementary treatment for individuals newly diagnosed with cancer. Its application frequently involves reducing tumor size, managing cancer progression, or eliminating cancerous cells prior to or following surgical procedures. An illustrative example can be seen in Australia, where, as reported in July 2024 by the Australian Institute of Health and Welfare, a government entity located there, the number of diagnosed cancer cases rose from 160,570 in 2022 to 164,694 in 2023, indicating a considerable increase annually. This observable upward trajectory underscores the rising incidence of cancer across the nation. Consequently, the expanding cancer prevalence is propelling the growth of the radiotherapy devices market.
Radiotherapy Devices Market Segment Trends And Revenue Contributors
The radiotherapy devices market covered in this report is segmented –
1) By Product Type: External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices
2) By Application: Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications
3) By End Users: Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers
Subsegments:
1) By External Beam Radiation Therapy Devices: Intensity-Modulated Radiation Therapy (IMRT) Devices, Image-Guided Radiation Therapy (IGRT) Devices, Stereotactic Body Radiation Therapy (SBRT) Devices, Stereotactic Radiosurgery (SRS) Devices, 3D Conformal Radiation Therapy (3D CRT) Devices
2) By Linear Accelerator Devices: Conventional Linear Accelerators, Stereotactic Linear Accelerators
3) By Proton Therapy Devices: Cyclotron-Based Devices, Synchrotron-Based Devices, Synchrocyclotron-Based Devices
#Radiotherapy Devices Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the radiotherapy devices market are introducing advanced technologies, such as The Versa HD, to boost their earnings within the sector. The Versa HD functions as a linear accelerator system specifically for radiation therapy. For example, in May 2023, the Mitchell Cancer Institute, a US-based facility specializing in cancer treatment, unveiled new radiation technology named The Versa HD. This Versa HD system is able to provide Volumetric Modulated Arc Therapy (VMAT), which accelerates the administration of treatments and improves the patient’s experience. High-Definition Dynamic Radiosurgery (HDRS), which possesses unique sequencing capabilities and transforms the linac into a specialized SRS solution, is another service that The Versa HD is equipped to offer.
Radiotherapy Devices Market Key Players Shaping Industry Direction
Major companies operating in the radiotherapy devices market are Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.,
View The Full Radiotherapy Devices Market Report:
Radiotherapy Devices Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the radiotherapy devices market in 2025. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
